Confusion around Certification of Vision Impairment (CVI) and registration processes-are patients falling through the cracks?


Journal

Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 21 11 2022
accepted: 31 03 2023
revised: 29 03 2023
medline: 9 11 2023
pubmed: 20 4 2023
entrez: 19 04 2023
Statut: ppublish

Résumé

In the UK, the Certificate of Vision Impairment (CVI) certifies a person as sight impaired (partially sighted) or severely sight impaired (blind). This is completed by ophthalmologists and passed with the patient's consent to their GP, their local authority, and The Royal College of Ophthalmologists Certifications office. Once a person is certified, they can be registered by their local authority which is voluntary but enables the person to access rehabilitation or habitation services, financial concessions, welfare benefits and other services provided by local authorities. We conducted semi-structured individual interviews with 17 patients with a diagnosed eye condition, 4 Eye Clinic Liaison Officers (ECLO) and 4 referring optometrists around their experiences around CVI and registration processes. Analysis of themes was conducted with results synthesised in a narrative analysis. Patients reported lack of clarity around the processes of certification and registration, benefits of certification and what happens beyond certification, the type of support that they are entitled to, delays in accessing support. Optometrists appear not to engage with the process much, especially if the patient is being treated by the hospital eye service. Vision loss can be a devastating experience for the patient. There is a lack of information and confusion around the process. The lack of a joined-up process between certification and registration needs to be addressed if we are to provide the support that patients deserve in order to improve their quality of life and wellbeing.

Sections du résumé

BACKGROUND BACKGROUND
In the UK, the Certificate of Vision Impairment (CVI) certifies a person as sight impaired (partially sighted) or severely sight impaired (blind). This is completed by ophthalmologists and passed with the patient's consent to their GP, their local authority, and The Royal College of Ophthalmologists Certifications office. Once a person is certified, they can be registered by their local authority which is voluntary but enables the person to access rehabilitation or habitation services, financial concessions, welfare benefits and other services provided by local authorities.
METHODS METHODS
We conducted semi-structured individual interviews with 17 patients with a diagnosed eye condition, 4 Eye Clinic Liaison Officers (ECLO) and 4 referring optometrists around their experiences around CVI and registration processes. Analysis of themes was conducted with results synthesised in a narrative analysis.
RESULTS RESULTS
Patients reported lack of clarity around the processes of certification and registration, benefits of certification and what happens beyond certification, the type of support that they are entitled to, delays in accessing support. Optometrists appear not to engage with the process much, especially if the patient is being treated by the hospital eye service.
CONCLUSION CONCLUSIONS
Vision loss can be a devastating experience for the patient. There is a lack of information and confusion around the process. The lack of a joined-up process between certification and registration needs to be addressed if we are to provide the support that patients deserve in order to improve their quality of life and wellbeing.

Identifiants

pubmed: 37076690
doi: 10.1038/s41433-023-02520-0
pii: 10.1038/s41433-023-02520-0
pmc: PMC10630472
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3412-3416

Informations de copyright

© 2023. The Author(s).

Références

Eye (Lond). 2012 Oct;26(10):1302-9
pubmed: 22814804
BMJ Open. 2014 Apr 08;4(4):e004319
pubmed: 24713212
BMC Health Serv Res. 2013 Nov 19;13:482
pubmed: 24252205
Eye (Lond). 2020 Jul;34(7):1271-1278
pubmed: 32291405
Eye (Lond). 2021 Jun;35(6):1644-1650
pubmed: 32839558

Auteurs

Shahina Pardhan (S)

Vision and Eye Research Institute, Anglia Ruskin University, Cambridge, UK. shahina.pardhan@aru.ac.uk.

Robin Driscoll (R)

Vision and Eye Research Institute, Anglia Ruskin University, Cambridge, UK.

Hilary Ingleton (H)

Royal National Institute of Blind People, London, UK.

John Slade (J)

Royal National Institute of Blind People, London, UK.

Michael Bowen (M)

College of Optometrists, London, UK.

Rupal Lovell-Patel (R)

NHS England and NHS Improvement, Cambridge, UK.

Sarah Farrell (S)

Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK.

Rupert Bourne (R)

Vision and Eye Research Institute, Anglia Ruskin University, Cambridge, UK.

Simon Mahoney (S)

Department of Information Studies, University College London, London, UK.

Sanjiv Ahluwalia (S)

School of Medicine, Anglia Ruskin University, Cambridge, UK.

Mike Trott (M)

Vision and Eye Research Institute, Anglia Ruskin University, Cambridge, UK.
Centre for Public Health, Queen's University Belfast, Belfast, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH